Selected article for: "bacterial infection and COPD exacerbation"

Author: Aran Singanayagam; Su-Ling Loo; Maria Calderazzo; Lydia J Finney; Maria-Belen Trujillo Torralbo; Eteri Bakhsoliani; Jason Girkin; Punnam Veerati; Prabuddha S Pathinayake; Kristy S Nichol; Andrew Reid; Joseph Foottit; Sebastian L Johnston; Nathan W Bartlett; Patrick Mallia
Title: Anti-microbial immunity is impaired in COPD patients with frequent exacerbations
  • Document date: 2019_5_9
  • ID: 72jzqm86_52
    Snippet: Genetic MBL deficiency has been previously shown to be associated with both increased 25, 36 and reduced 37 exacerbation frequency in COPD. Although serum MBL concentrations have been shown to not differ between frequent and infrequent exacerbators 36 , a previous study reported reduced bronchoalveolar lavage MBL concentrations in COPD versus healthy subjects 38 . Our data extends these observations by demonstrating that deficient airway MBL-2 at.....
    Document: Genetic MBL deficiency has been previously shown to be associated with both increased 25, 36 and reduced 37 exacerbation frequency in COPD. Although serum MBL concentrations have been shown to not differ between frequent and infrequent exacerbators 36 , a previous study reported reduced bronchoalveolar lavage MBL concentrations in COPD versus healthy subjects 38 . Our data extends these observations by demonstrating that deficient airway MBL-2 at baseline and during subsequent exacerbation might predispose frequent exacerbators to increased secondary bacterial infection. A previous study reported that the presence of rhinovirus is associated with increased S.pneumoniae colonization in children with MBL gene polymorphisms, further suggesting a role for MBL in virusinduced secondary bacterial infection 39 . Given that nebulised plasma-derived MBL has been shown to restore phagocytic function in smoke-exposed mice 40 , our data raise speculation that administration of MBL could additionally be considered as an effective preventative and/or therapeutic strategy for COPD exacerbations. Further studies are needed to evaluate this.

    Search related documents:
    Co phrase search for related documents
    • bacterial infection and copd exacerbation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • bacterial infection and deficient airway: 1
    • bacterial infection and evaluate need: 1
    • bacterial infection and exacerbation frequency: 1, 2, 3, 4
    • bacterial infection and frequent exacerbator: 1, 2
    • bacterial infection and MBL role: 1
    • bacterial infection and phagocytic function: 1, 2
    • bacterial infection and previous study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • bacterial infection and secondary bacterial infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78
    • bacterial infection and secondary bacterial infection increase: 1, 2
    • bacterial infection and subsequent exacerbation: 1, 2
    • bacterial infection and therapeutic strategy: 1, 2, 3
    • bronchoalveolar lavage and copd exacerbation: 1, 2, 3
    • bronchoalveolar lavage and deficient airway: 1
    • bronchoalveolar lavage and previous study: 1, 2, 3, 4
    • bronchoalveolar lavage and reduce bronchoalveolar lavage: 1, 2, 3
    • bronchoalveolar lavage and rhinovirus presence: 1
    • bronchoalveolar lavage and secondary bacterial infection: 1, 2, 3, 4, 5, 6, 7, 8
    • bronchoalveolar lavage and therapeutic strategy: 1, 2, 3, 4, 5, 6